managment of oligohydramnios
- Conditions
- oligohydramnios
- Registration Number
- PACTR201411000920150
- Lead Sponsor
- menoufiya university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 184
Pregnant women will be included if they are of any age, any parity, carrying a singleton pregnancy, at a gestational age (GA) 30 weeks or more (based on the last menstrual period and confirmed by the results of ultrasound or determined through early pregnancy sonography), they have an AFI ¿ 5, no pregnancy complications such as preeclampsia, gestational hypertension, or diabetes, no prior history of kidney, lung, and heart disease (the use of bolus-fluid therapy is contraindicated in these patients), and intact fetal membranes.
Mothers treated with prostaglandin synthetase inhibitors, well established labor, evidence of fetal distress (non-reactive non stress test), or fetal complications (intrauterine growth retardation or obvious fetal anomalies) are considered exclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the values of AFI before and after therapy in each group and between both groups.
- Secondary Outcome Measures
Name Time Method